Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Malaria vaccines-how and when to proceed
Trends in Parasitology, 11/03/09
Craig AG et al. – In the field of malaria vaccines, there are many barriers to moving lead candidates from the bench into developmental programmes before clinical testing. Many of the same challenges are to be found in the field of vaccines for other infectious diseases. Here, the authors briefly outline the process of pre–clinical development to help identify ways to support the translation of laboratory–based information into viable vaccine candidates.
Related Articles
Worlds largest malaria vaccine trial now underway in seven African countries
GlaxoSmithKline, 11/04/09
Relevance Score: 68%
Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage associated P. falciparum protein PFF0165c
Infection and Immunity, 10/19/09
Relevance Score: 68%
The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas
Malaria Journal, 10/30/09
Relevance Score: 67%
Prime-boost immunization with adenoviral and MVA vectors enhances the durability and polyfunctionality of protective malaria CD8+ T cell responses
Infection and Immunity, 11/16/09
Relevance Score: 66%
Pneumonia Can Be Prevented - Vaccines Can Help
MedLinePlus, 11/04/09
Relevance Score: 65%
Today in Tropical/Parasitology...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute acalculous cholecystitis complicating an imported case of mixed malaria caused by Plasmodium falciparum and Plasmodium vivax
International Journal of Infectious Diseases, 11/24/09
Cellular response to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection
Malaria Journal, 11/24/09
Factors associated with use and non-use of mosquito nets owned in Oromia and Amhara Regional States, Ethiopia
Malaria Journal, 11/24/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection
Mucosal Immunology, 11/24/09
Coverage and Predictors of Adherence to Influenza Vaccination among Spanish Children and Adults with Asthma
Infection, 11/23/09
Towards the Rational Design of a Malaria Vaccine Construct; Example of the MSP3 Family, Part II: Antigenicity Studies
Infection and Immunity, 11/23/09
Article Search
Sponsor


See Latest Articles


